Titlebook: Mastering the Acquirer‘s Innovation Dilemma; Knowledge Sourcing T Valerie Bannert-Thurner Book 2005 Palgrave Macmillan, a division of Macmi

只看該作者 · 發(fā)表于 2025-3-27 06:42:04

Valerie Bannert-Thurnerque and what their characteristics are. Practical questions such as supply of natural substances and production optimization strategies are also covered..978-3-7643-8595-8Series ISSN 0071-786X Series E-ISSN 2297-4555

只看該作者 · 發(fā)表于 2025-3-27 11:31:45

Valerie Bannert-Thurnero B), which are currently at various stages of clinical evaluation in humans. The most advanced of these compounds, Epo B lactam BMS-247550 (ixabepilone), has recently obtained FDA approval for the treatment of metastatic and advanced breast cancer. This chapter will first provide a summary of the b

只看該作者 · 發(fā)表于 2025-3-27 14:58:35

只看該作者 · 發(fā)表于 2025-3-27 19:25:39

只看該作者 · 發(fā)表于 2025-3-27 23:42:12

978-1-349-52439-6Palgrave Macmillan, a division of Macmillan Publishers Limited 2005

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-26 08:47
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved